Q/C TECHNOLOGIES, INC. — Director's Dealing 2021

Apr 27, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2021-04-16

Reporting Person: Williams Caroline C (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1272972	Direct
Common Stock	2471479	Indirect
Common Stock	1272972	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$	2023-04-16	Common Stock (1275731)		Indirect

Footnotes

F1: Received in exchange for shares of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") in connection with the merger of the Former Entity with a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share (after giving effect to a reverse stock split on April 19, 2021).

F2: The reporting person is a trustee of the trust and a beneficiary of the trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

F3: The reporting person is a beneficiary of the trust but not a trustee. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

F4: These options are fully vested and exercisable.

F5: Received in the Merger in exchange for a stock option to acquire shares of the Former Entity at $1.00 per share.